# Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.

> **NCT03733002** · PHASE3 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** AngongNiuhuang pill
- **DRUG:** Placebo of AngongNiuhuang pill
- **OTHER:** Standard treatment

## Key facts

- **NCT ID:** NCT03733002
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-11-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733002, "Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03733002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*